Dehydrocrenatidine
CAS No. 65236-62-6
Dehydrocrenatidine ( 去氢苦木碱 )
产品货号. M39685 CAS No. 65236-62-6
Dehydrocrenatidine 是天然的生物碱,是特异性的 JAK 抑制剂。Dehydrocrenatidine在大鼠神经痛模型中抑制电压门控钠通道并改善机械性异位。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 25MG | 获取报价 | 有现货 |
|
| 50MG | 获取报价 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Dehydrocrenatidine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Dehydrocrenatidine 是天然的生物碱,是特异性的 JAK 抑制剂。Dehydrocrenatidine在大鼠神经痛模型中抑制电压门控钠通道并改善机械性异位。
-
产品描述Dehydrocrenatidine, a natural alkaloid, is a specific JAK inhibitor. Dehydrocrenatidine inhibits voltage-gated sodium channels and ameliorates mechanic allodia in a rat model of neuropathic pain.
-
体外实验Dehydrocrenatidine inhibits JAK-STAT3 dependent DU145 and MDA-MB-468 cell survival and induces cell apoptosis. Dehydrocrenatidine inhibits JAKs-JH1 domain over-expression induced STAT3 and STAT1 phosphorylations.Dehydrocrenatidine diminishes IL-6, IFNα and IFNγ stimulated STAT3 phosphorylation as well as constitutive STAT3 phosphorylation.DHCT suppresses both tetrodotoxin-resistant (TTX-R) and sensitive (TTX-S) voltage-gated sodium channel (VGSC) currents with IC50 values of 12.36 μM and 4.87 μM, respectively.
-
体内实验Dehydrocrenatidine inhibits JAK-STAT3 dependent DU145 and MDA-MB-468 cell survival and induces cell apoptosis. Dehydrocrenatidine inhibits JAKs-JH1 domain over-expression induced STAT3 and STAT1 phosphorylations.Dehydrocrenatidine diminishes IL-6, IFNα and IFNγ stimulated STAT3 phosphorylation as well as constitutive STAT3 phosphorylation.DHCT suppresses both tetrodotoxin-resistant (TTX-R) and sensitive (TTX-S) voltage-gated sodium channel (VGSC) currents with IC50 values of 12.36 μM and 4.87 μM, respectively.
-
同义词去氢苦木碱
-
通路Others
-
靶点Other Targets
-
受体———
-
研究领域———
-
适应症———
化学信息
-
CAS Number65236-62-6
-
分子量254.28
-
分子式C15H14N2O2
-
纯度>98% (HPLC)
-
溶解度———
-
SMILESO(C)C1=C2C=3C(NC2=C(C=C)N=C1)=C(OC)C=CC3
-
化学全称O(C)C1=C2C=3C(NC2=C(C=C)N=C1)=C(OC)C=CC3
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Jing Zhang, et al. Dehydrocrenatidine is a novel janus kinase inhibitor. Mol Pharmacol. 2015 Apr;87(4):572-81.?
产品手册
关联产品
-
Canertinib
Canertinib 是一种泛 erbB 酪氨酸激酶抑制剂,可在体外和体内对抗食管鳞状细胞癌。
-
5-O-Methylvisammiosi...
5-O-甲基维三胺苷是从著名的中草药防风中分离出来的天然化合物。
-
Dihydrohomocapsaicin...
Dihydrohomocapsaicin II
021-51111890
购物车()
sales@molnova.cn

